Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
Clinical trial NCT04947319 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04947319
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-29
- Primary completion
- 2026-01-27
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.